- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 10, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,584 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NVG | zł2.14 | 7.0% | 25.9% | zł74.9m | zł3.71 | PE14.8x | E29.0% | n/a | Diversified Financials | ||
RCEL | US$8.26 | -5.6% | -31.8% | US$224.7m | US$25.90 | PS4.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
ERO | CA$29.43 | 3.2% | 23.9% | CA$3.1b | CA$31.63 | PE36x | E35.5% | n/a | Materials | ||
AESI | US$22.72 | 3.4% | 34.6% | US$2.5b | US$26.00 | PE20.1x | E49.3% | 3.7% | Energy | ||
ARES | US$142.27 | 7.9% | 73.5% | US$44.1b | US$147.64 | PE64.4x | E41.9% | 2.6% | Diversified Financials | ||
AVLL3 | R$3.78 | -0.5% | 5.3% | R$738.3m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
CALTX | kr110.80 | 3.9% | -14.5% | kr5.9b | kr208.00 | PS4.9x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €35.95 | 5.7% | 0% | €188.0m | €64.07 | PE23.9x | E37.6% | n/a | Energy | ||
GIG | kr32.10 | -4.7% | 14.6% | kr4.1b | kr45.03 | PE18.8x | E38.8% | n/a | Consumer Services | ||
NOHAL | kr23.00 | -0.9% | -7.3% | kr899.4m | kr32.50 | PS8.8x | E56.0% | n/a | Food, Beverage & Tobacco | ||
ELABS | kr15.70 | 0.4% | 38.9% | kr1.6b | kr25.00 | PS24.1x | E124.6% | n/a | Software | ||
ASND | US$133.46 | -2.7% | 39.9% | US$7.6b | US$180.08 | PS26.5x | E65.0% | n/a | Pharmaceuticals & Biotech | ||
WAYS | kr21.90 | -6.8% | -51.8% | kr176.7m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
ATAKP | ₺44.60 | -5.5% | n/a | ₺6.2b | ₺67.66 | PE20.9x | E72.8% | n/a | Food, Beverage & Tobacco | ||
TGTX | US$16.62 | 2.7% | -46.2% | US$2.4b | US$31.50 | PE57.7x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.63 | 1.9% | 162.3% | €123.3m | €9.70 | PS20.4x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$164.09 | 2.5% | 81.7% | US$9.5b | US$205.92 | PE70.4x | E26.4% | n/a | Household | ||
AXSM | US$72.50 | -3.1% | -8.2% | US$3.5b | US$123.56 | PS13.7x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
AGP | €8.32 | 0% | 157.6% | €144.0m | €12.75 | PE29.3x | E22.8% | n/a | Capital Goods | ||
RDUE | €9.65 | 0% | -0.5% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
GWIND | ₺29.02 | -1.5% | 105.8% | ₺15.7b | ₺39.79 | PE25.1x | E60.9% | 1.6% | Utilities | ||
NEWBRY | kr3.27 | 1.2% | -40.3% | kr79.3m | kr8.00 | PS3.5x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.47 | -2.4% | 39.6% | kr397.5m | kr2.20 | PS4.4x | E90.4% | n/a | Tech | ||
OSE | €6.75 | 8.9% | 78.1% | €145.6m | €7.15 | PS65.4x | E92.9% | n/a | Pharmaceuticals & Biotech |